Objective To elucidate the persistence, or otherwise, of the pregnancy-related changes in the iodine metabolism and thyroid function in a population residing in an area of mild iodine de®ciency in the Sudan. Design: A longitudinal prospective cohort study involving pregnant women who were recruited during their third trimester of pregnancy and were followed up for up to nine months after delivery. Setting: The study was conducted among Sudanese women residing in the Omdurman area in Khartoum, an area with a total goitre rate of 17.5%. Subjects: Forty-seven pregnant women were recruited during their third trimester of pregnancy. Their mean age and weight were 29 AE 4.6 y and 62.4 AE 8.7 kg, respectively. Age matched healthy non-pregnant women living in the same area (n 40) served as a control group. Methods: Serum levels of thyrotropin (TSH), thyroxine (T4), triiodothyronine (T3), thyroglobulin (Tg) and the urinary iodine concentration (UIC) were determined during the third trimester (®rst occasion), and subsequently at three months (second occasion), six months (third occasion) and nine months after delivery (fourth occasion). Control subjects provided corresponding samples on one occasion. Main outcomes measures: UIC, TSH, Tg, FT4 and T3. Results: During the third trimester of pregnancy the median UIC and the free T4 (FT4) were lower than in the control group (P`0.0001, P`0.0001, respectively), while the median Tg was higher than in the controls (P`0.03). Three months post-partum maximum thyroidal stimulation was evident, with elevated serum levels of TSH and Tg (P`0.0001, P`0.03) and reduced UIC and serum T3 and FT4 (P`0.0004, P`0.0005, P`0.0001), compared with the control group. Nine months post-partum the thyroid function was restored to the pre-pregnancy state, and the median values of TSH, Tg, T3, FT4 and UIC did not differ signi®cantly from those in the control group. Conclusions: Our study suggests that the reversibility of the pregnancy-induced changes in the iodine status and thyroid function to the pre-pregnancy levels may depend on the iodine status of the mother during and after pregnancy. The thyroidal stress during the ®rst three months of the post-partum period, which is partially due to the iodine loss in the breast milk, justi®es further detailed studies to assess the iodine content of the breast milk and the role of breast milk as a vehicle for iodine supply of infants in situations of iodine de®ciency.
Introduction
During normal pregnancy, which is characterised by abundance of oestrogen, the circulating level of thyroxine binding globulin (TBG) increases, leading to a transient reduction of the free hormone fraction in the blood (Glinoer, 1997a) . This reduction in the free hormone levels in turn stimulates the secretion of thyroid stimulating hormone (TSH) in order to adjust the circulating hormones levels to normal, provided the iodine intake is adequate. Other pregnancy-induced physiological changes such as an increased glomerular ®ltration rate and increased secretion of human chorionic gonadotrophin (HCG) are also known to affect the maternal thyroid function. Increased renal clearance of iodide leads to increased iodide loss and this reduction in the available iodine is further aggravated during the second half of pregnancy by the diversion of iodide to the foeto-placental complex (Glinoer, 1997a) . HCG, which is secreted by the syncytiotrophoblastic cells during the end of the ®rst trimester, is considered to be a natural thyroid regulator during normal pregnancy, because of its thyrotropic action, which is similar to but weaker than that of TSH (Glinoer, 1997b) . In the face of all these physiological processes, the thyroid gland maintains an adequate thyroxine production for normal foetal growth and development, provided that the intake of iodine has been suf®cient.
In situations of inadequate iodine intake during pregnancy, the transient reduction of the free hormones fraction will be more prolonged and aggravated and the thyroid gland will not be able to maintain production of a thyroxine supply that is adequate for both the foetus and the mother. In a previous investigation of Swedish and Sudanese pregnant women, we found that the Swedish women showed a decline in FT4 and a rise in TSH with the progression of pregnancy, while the Sudanese women with (Eltom 1999a,b) and without (Elnagar et al, 1998) goitre displayed a reduction both in FT4 and in the urinary iodine concentration (UIC), but a stable TSH within the reference range. Our interpretation of those ®ndings, as in similar other studies, was that both of these groups of pregnant women, although exhibiting different behaviour in their iodine metabolism in response to pregnancy, were likely to be in need of additional iodine intake during gestation.
The pregnancy-induced physiological and adaptive processes can extend into the post-partum period, although this issue has not been adequately investigated and only limited systematic studies are available. No such studies have been carried out in either Sweden or Sudan. The aim of the present study was therefore to elucidate the persistence or otherwise of the pregnancy-related changes in the iodine metabolism and thyroid function in a population residing in an area of mild iodine de®ciency in the Sudan.
Material and methods

Subjects
The study was conducted among Sudanese women residing in the Omdurman area in Khartoum, an area with a total goitre rate of 17.5% (Eltom, 1984) .
Fifty healthy pregnant women were recruited during the third trimester of pregnancy and were followed-up for up to nine months after delivery. The subjects were enrolled during their visits to the antenatal follow-up at the Health Centre. Women on any thyroid function modfying medication were excluded from the study. Three of the women did not complete the study because of a change of residence (n 2) or for personal reasons (n 1). The prospective longitudinal study is thus based on 47 women. Their mean age and weight were 29 AE 4.6 y and 62.4 AE 8.7 kg, respectively.
Another group of healthy non-pregnant women living in the same area (n 40) with age range 23 ± 34 y and weight range 52 ± 76 kg, served as a control group. All subjects gave their informed consent prior to the study.
Sample collection
All subjects provided about 10 ml of venous blood during the third trimester (®rst occasion), and subsequently three months (second occasion), six months (third occasion) and nine months after delivery (fourth occasion). The blood was taken from the cubital vein into acid-rinsed vacutainers. The blood samples were allowed to coagulate at room temperature before separation of the serum by centrifugation. The serum samples were frozen within 2 h of sampling and then kept frozen at À20 C pending analysis. Twenty-four-hour urine samples were obtained from all the subjects on the same occasions as the blood sampling. Urine volumes were measured, and approximately 20 ml aliquots were then taken and kept frozen until analysed.
Control subjects provided corresponding samples on one occasion, and the samples were treated as above.
Analytical procedures
Urinary iodine concentrations were determined in Uppsala, Sweden by a modi®ed Sandell ± Kolthoff method (Sandell and Kolthoff, 1935) , using a Hitachi, Tokyo, Japan U2000 spectrophotometer. The coef®cient of variation for duplicate standard samples is less than 3%. The within-series coef®cient of variation was less than 8% and the betweenseries variation was less than 10%. UIC of 1 mmolal 12.7 mgad.
TSH was measured with a sandwich TR-FIA (Del®a TM hTSH Ultra, Wallac Oy, Turku, Finland).
Thyroglobulin (Tg) was measured in serum by radioimmunoassay using a polyclonal rabbit antiserum raised against human thyroglobulin, puri®ed under protease protection as described elsewhere (Eriksson et al, 1984) . Human thyroglobulin, obtained from Immunogen International (Gateshead, UK), was used as the standard and for the preparation of the 125-iodine tracer. Bound and free fractions were separated by the double-antibody technique (goat-antirabbit antiserum). The total imprecision of the method was 7.6% at the level of 9 mgal and 5.1% at the level of 22 mgal. The detection limit was 1 mgal. The reference value at the laboratory for healthy adult subjects is 0 ± 40 mgal.
T3 and FT4 were measured with solid phase timeresolved¯uoroimmuno assay (TR-FIA) (Del®a TM, Wallac Oy, Turku, Finland). For T3 the reference range in Swedish adult non-pregnant subjects is 1.2 ± 2.8 nmolal and for FT4 9 ± 21 pmolal.
Statistical analysis
Basic statistical analysis was carried out by using the StatView program. The data are not normally distributed. The Mann-Whitney U-test was used for independent data, and the Wilcoxon signed rank test was used for paired data.
Results
The median values (and interquartile ranges) for UIC, TSH, Tg, FT4 and T3 are given in Table 1 and Figures 1 ± 3. UIC UIC was low during the third trimester of pregnancy, at which time it was signi®cantly lower than that in the control group (P`0.0001). It then increased to reach a maximum nine months after delivery, which was signi®-cantly higher than that during the third trimester of pregnancy but not statistically different from that in the nonpregnant group (P`0.0001, P`0.07, respectively). Both three and six months after delivery, the median UIC values were lower than the median value in the non-pregnant women (P`0.0004, P`0.0001).
TSH
The median TSH concentration in the third trimester of pregnancy was 1.0 (0.8 ± 1.9) mUal and this had increased to 2.2 (1.7 ± 2.7) mUal three months after delivery, a value which was higher than the median value nine months after delivery as well as that in the control group (P`0.0001, P`0.0001, respectively). By six and nine months after delivery the median concentrations of TSH were 1.6 and Changes in iodine metabolism during late pregnancy and lactation A Eltom et al 1.7 mUal, respectively. These values were not signi®cantly different from the median value in the non-pregnant control group.
Tg
The median Tg concentration in the third trimester was signi®cantly higher than that in the non-pregnant control women (P`0.04). It increased to reach a maximum three months after delivery and was higher than the median value nine months after delivery as well as that in the control group (P`0.0001, P`0.03, respectively). Six months after delivery it was still higher than that in the control group (P`0.05). The median Tg level nine months after delivery was 24.0 mgal, which was not signi®cantly different from that in the non-pregnant control subjects (P`0.17).
T3
The median T3 concentration in the third trimester of pregnancy was 2.6 nmolal, and this had decreased to 2.2 nmolal three months after delivery, which was lower than that in the non-pregnant control group (P`0.0005). By six and nine months after delivery the median T3 levels were not signi®cantly different from the median value in the non-pregnant control group.
FT4
The median FT4 concentration increased from 9.7 pmolal three months after delivery to 10.4 pmolal nine months after delivery. Both these levels were signi®cantly higher than the median value in the third trimester of pregnancy (P`0.001, P`0.001, respectively). The median FT4 concentration during the third trimester of pregnancy, as well as those three and six months after delivery, was signi®-cantly lower than the median value in the non-pregnant women (P`0.0001, P`0.0001, P`0.01, respectively). There was no signi®cant difference between the median value nine months after delivery and that in the control, non-pregnant group (P`0.2).
Lactation
We did not study the iodine content of the breast milk of the recruited subjects. However, none of the recruited women stopped breast feeding before nine months. Table 1 The median values and interquartile ranges of urinary iodine concentration (UIC), thyroid stimulating hormone (TSH), thyroglobulin (Tg), triiodothyronine (T3) and free thyroxine (FT4) Parameter Non-pregnant controls (n 40) 3rd trimester 3 months postpartum 6 months post-partum 9 months post-partum UIC (mmolal) 0.6 (0.4 ± 0.9) 0.3 (0.1 ± 0.4) 0.4 (0.2 ± 0.5) 0.24 (0.20 ± 0.5) 0.5 (0.3 ± 0.8) TSH (mUal) 1.1 (0.8 ± 1.6) 1.0 (0.8 ± 1.9) 2.2 (1.7 ± 2.7) 1.6 (1.3 ± 2.4) 1.7 (1.1 ± 3.2) Tg (mgal) 15.5 (8.5 ± 28.5) 27 (13.5 ± 40) 29 (13.5 ± 44.5) 27 (14 ± 39.5) 24 (12.5 ± 45.2) T3 (nmolal) 2.6 (2.2 ± 3.2) 2.6 (2.2 ± 2.9) 2.2 (1.9 ± 2.5) 2.1 (2.0 ± 2.2) 2.1 (1.9 ± 2.2) FT4 (pmolal) 10.5 (9.6 ± 12.0) 8.7 (7.3 ± 9.4) 9.7 (8.5 ± 10.4) 9.6 (8.8 ± 11.1) 10.4 (7.9 ± 11.6) Figure 1 Changes in median urinary iodine concentration (UIC). The median UIC in the third trimester and that three and six months after delivery were signi®cantly lower than the median value in the nonpregnant women (**P`0.0001, *P`0.0004, **P`0.0001, respectively).
In nine months after delivery, it was signi®cantly higher than that during the third trimester of pregnancy (**P`0.0001). The central box covers the middle 50% of the data values, between the lower and upper quartile. The whiskers extend out to points that are within 1.5 times the interquartile range. Figure 2 Changes in median serum thyroglobulin (Tg). The median Tg concentration in the third trimester and that three and six months after delivery were signi®cantly higher than the median values in the nonpregnant women (**P`0.04, ***P`0.03, *P`0.05, respectively). The central box covers the middle 50% of the data values, between the lower and upper quartile. The whiskers extend out to points that are within 1.5 times the interquartile range. Figure 3 Changes in median serum free thyoxine (FT4). The median value in the third trimester of pregnancy was signi®cantly lower than that in three months and nine months after delivery (**P`0.0001, (**P`0.0001, respectively). The median FT4 concentrations during the third trimester of pregnancy and that 3 and 6 months after delivery were signi®cantly lower than the median value in the non-pregnant women (**P`0.0001, (**P`0.0001, *P`0.01, respectively). The central box covers the middle 50% of the data values, between the lower and upper quartile. The whiskers extend out to points that are within 1.5 times the interquartile range.
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Discussion
The current study is complementary to the comprehensive studies on iodine nutrition among pregnant women that we have conducted previously in Sudan and Sweden (Elnagar et al, 1998; Eltom et al, 1999a,b) . In these studies we looked at the changes in the thyroid function associated with pregnancy in populations residing in areas with variable amounts of iodine intake as represented by these two countries. However, the extent of these changes beyond the period of pregnancy has not been studied previously. Our aim in the present study was therefore to elucidate the postpartum thyroid function and the reversibility of pregnancyrelated changes in the iodine metabolism and thyroid function in a population residing in an area with iodine de®ciency in Sudan.
In the present study we followed up our subjects from the third trimester of pregnancy up to nine months after parturition. Apparently healthy non-pregnant women residing in the same area served as controls.
We found that in the last trimester of pregnancy, the women recruited in this study showed reduced median UIC values, compared to the non-pregnant controls. There are several possible explanations for this reduction in UIC. It may partially be due to the increased renal clearance of iodine which increases early in pregnancy and remains high throughout leading to decreased plasma inorganic iodine (Aboul-Khair et al, 1964) . The increased demand for iodine by the growing foetus will also account for an increased diversion of iodine from the maternal to the foetal pool during the second half of pregnancy (Glinoer et al, 1997a; Fisher 1983 ). As we found in our earlier study (Eltom et al, 1999a, b) , the median FT4 in late pregnancy was lower than that in non-pregnant control women, an observation in agreement with other reports regarding hypothyroxinaemia during late pregnancy (Silva et al, 1981) . Furthermore, the ®ndings in the current study regarding thyroglobulin during late pregnancy support these pregnancy-induced changes (Nakamura et al, 1984) , and con®rm our previous observation in a similar population (Eltom et al, 1999a,b) , in which we found that the Tg values were higher in pregnant women during the third trimester than in non-pregnant women.
The present study shows that the alterations in the iodine metabolism and thyroid function seen during pregnancy, which were charcterised by increased thyroid stimulation, persisted in the postpartum period, as evidenced by the elevated levels of TSH and Tg and the reduced levels of UIC, T3 and FT4. These ®ndings lead us to postulate that these changes during the ®rst three months post-partum suggest further deterioration of the maternal iodine status. This deterioration during the post-natal period may be due to breastfeeding, which may increase the demand for extra iodine intake placed by the sequestration of some of the maternal iodine pool to the breast milk (Delange et al, 1988) . Data concerning breast milk iodine content are seemingly scanty (Vermiglio et al, 1992) . Published reports indicate that the iodine content of human breast milk, at least in Europe, varies individually from 7.0 to 9.0 mgadl (Catala 1993) . On the basis of these considerations, all lactating women can be expected to lose some of their iodine in the breast milk and, unless they are adequately supplemented, this may lead to a reduced maternal iodine pool and consequently reduced thyroid hormone production.
In a previous study (Glinoer et al, 1992) it was found that the restoration of the thyroid function to the prepregnancy state occurred at about six months after delivery, with the exception of Tg and goitre, which persisted in some cases for up to one year post-natally. In the present study it took up to nine months after delivery before the thyroid function values had regained their pre-pregnancy levels. The discrepancy between our ®ndings and those of others may re¯ect a difference in iodine intake between the two populations, which may partially explain the patterns observed.
Our study suggests that the reversibility of the pregnancy-induced changes in the iodine status and thyroid function to the pre-pregnancy levels may depend on the iodine status of the mother during and after pregnancy. The thyroidal stress during the ®rst three months of the postpartum period, which is partially due to the iodine loss in the breast milk, justi®es further detailed studies to assess the iodine content of the breast milk and the role of breast milk as a vehicle for iodine supply of infants in situations of iodine de®ciency.
